Summary:

- The FDA (Food and Drug Administration) is planning to phase out the requirement for animal testing when developing new drugs, such as monoclonal antibodies.
- This change will allow researchers to use alternative methods that are more efficient and humane, without relying on animal experiments.
- The goal is to encourage the development of new drugs and treatments while reducing the use of animals in the testing process.